Instructions for Completing Transgenic Mouse ReadyToSign AgreementTransgenic Mouse Ready-to-Sign Agreement • August 24th, 2006
Mouse Strain (¶ 1.1) Inventor (¶ 1.1) Docket Number (¶ 1.1) Sponsor (¶ 1.5) Description (¶ 2.1) HHMIRights? (¶ 4.2) “Mouse Model for Phosphodiesterase Deficiency (PDE4D)” Dr. Marco Conti S98097 National Institutes of Health Transgenic mice with a null PDE4D gene No “Mouse Model for Phosphodiesterase (PDE4B) Deficiency” Dr. Marco Conti S99179 National Institutes of Health Transgenic mice with a null PDE4B gene No “Mouse Model for Phosphodiesterase (PDE4A) Deficiency” Dr. Marco Conti S05018 National Institutes of Health Transgenic mice with a null PDE4A gene No “Alpha 2a Adrenergic Receptor Gene Disruption Mouse (A2aARGDM)” Dr. Brian Kobilka S97236 National Institutes of Health Transgenic mice with a null alpha 2a adrenergic receptor gene Yes “Alpha 2b Adrenergic Receptor Gene Disruption Mouse (A2bARGDM)” Dr. Brian Kobilka S97237 National Institutes of Health Transgenic mice with a null alpha 2b adrenergic receptor gene Yes “Alpha 2c Adrenergic Receptor Gene Disruption Mouse (A2cARG
